Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 5,076–5,100 of 27,380 studies, newest first · page 204 of 1096.

March 2025 25

  1. 2025-03-01
  2. 2025-03-01

    Social Isolation as a Risk Factor for Dementia: Insights from Animal Model Studies

    ✓ Peer-reviewed Risk factors Current Alzheimer Research

    Key finding: Intriguingly, recent reports have shown a significant association of loneliness with a higher amyloid- β (Aβ) burden, suggesting that SI is linked to the pathophysiology of AD. +4 more findings

  3. 2025-03-01
  4. 2025-03-01
  5. 2025-03-01

    Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    Key finding: The overall rate of dementia was higher in PLHIV than that in POHIV (22% vs 10%; p = 1.4e). +4 more findings

  6. 2025-03-01

    A deep‐learning retinal aging biomarker for cognitive decline and incident dementia

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    Key finding: Of 510 memory-clinic subjects(N = 155 cognitive decline), RetiPhenoAge associated with incident cognitive decline (subdistribution hazard ratio [SHR] 1.34, 95% confidence interval [CI] 1.10-1.64, p = 0.004), and incident dementia (SHR 1.43, 95% CI 1.02-2.01, p = 0.036). +4 more findings

  7. 2025-03-01

    Blood DNA methylation signature for incident dementia: Evidence from longitudinal cohorts

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    Key finding: Meta-analysis identified 44 CpGs and 44 differentially methylated regions consistently associated with time to dementia in both cohorts. +4 more findings

  8. 2025-03-01

    Social determinants of health and risk of dementia among older men and women: A 12‐year cohort study in Australia

    ✓ Peer-reviewed How common it is Alzheimer s & Dementia

    Key finding: Four clusters were identified: least disadvantaged (Class 1: 31.5% men; 30.6% women), most disadvantaged (Class 2: 20.2% men; 19.4% women), high social support with Class 1 features (Class 3: 22.2% men; 24.1% women), and high social support with Class 2 features (Class 4: 26.1% men; 25.7% women). +4 more findings

  9. 2025-03-01

    Community Input for Addressing Dementia Health Disparities: Richmond Brain Health Initiative

    ✓ Peer-reviewed Disparities Progress in community health partnerships

    Key finding: Based on the stakeholder responses from fifteen providers and twenty community members, there was strong consensus in the need for local brain health services. +4 more findings

  10. 2025-03-01
  11. 2025-03-01

    Barriers to Accessing Care and Support Services for Older Immigrants and Immigrants with Dementia in Finland: Perspectives of Professional Social and Health Care Providers

    ✓ Peer-reviewed Caregiving Journal of Cross-Cultural Gerontology

    Key finding: This study addresses this gap in the research and employs semi-structured qualitative interviews with professionals offering services to this target group. +4 more findings

  12. 2025-03-01

    Clinician type and care setting for treatment of Medicare beneficiaries with dementia

    ✓ Peer-reviewed Caregiving Alzheimer s & Dementia

    Key finding: A total of 1,934,318 PLWD received care from 783,225 unique clinicians in 2019; PLWD saw a median of eight clinicians (interquartile range 5, 14). +4 more findings

  13. 2025-03-01

    Optimizing Advance Care Planning in Dementia: Recommendations From a 33-Country Delphi Study

    ✓ Peer-reviewed Caregiving Journal of Pain and Symptom Management

    Key finding: Thirty constitutive elements of ACP were identified (e.g., 'assess understanding of ACP'). +4 more findings

  14. 2025-03-01

    A look at caregivers for community‐living persons with dementia: Implications for the GUIDE model

    ✓ Peer-reviewed Caregiving Alzheimer s & Dementia

    Key finding: Half of GUIDE-eligible PwD received care from multiple caregivers and high strain was common even among caregivers considered "low-complexity" under GUIDE. +4 more findings

  15. 2025-03-01

    Burden and care time for dementia caregivers in the LIVE@Home.Path trial

    ✓ Peer-reviewed Caregiving Alzheimer s & Dementia

    Key finding: Caregivers during the intervention period reported lower levels of RSS of 0.7 points (standard deviation [SD]: 0.8) compared to the caregivers in the control period. +4 more findings

  16. 2025-03-01

    Perfusionsmuster der [18F]PI-2620-Tau-PET bei verschiedenen neurodegenerativen Tauopathien

    ✓ Peer-reviewed Brain scans and imaging Nuklearmedizin - NuclearMedicine

    Key finding: Die Frühphasen- & R1-Bilder korrelierten signifikant in allen Gruppen (Gesunde: r=0,68-0,84; AD: r=0,81-0,9; PSP-RS: r=0,81-0,86; FTD: r=0,76-0,82). +4 more findings

  17. 2025-03-01

    Entorhinal tau impairs short-term memory binding in preclinical Alzheimer’s disease

    ✓ Peer-reviewed Brain scans and imaging Journal of the International Neuropsychological Society

    Key finding: Aβ + CN individuals performed worse than Aβ-CN participants in the SCBC while the SOC only distinguished Aβ − CN from MCI participants. +3 more findings

  18. 2025-03-01

    Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies

    ✓ Peer-reviewed Getting a diagnosis Journal of Alzheimer s Disease

    Key finding: Alpha-synuclein (a-syn) and tau species have been detected in peripheral tissues and biological fluids of DLB patients and among different biological fluids, saliva represent an easely accessible and non-invasive source for biomarker detection. +1 more finding

  19. 2025-03-01

    Cognitive assessment across normal aging and subjective cognitive decline using PGIMS and Stroop color-word test: A cross-sectional study

    ✓ Peer-reviewed Getting a diagnosis Archives of Gerontology and Geriatrics Plus

    Key finding: SCD individuals scored significantly lower in the Stroop color-word tests (SCWT), and delayed recall memory in PGIMS (Co-efficient: -0.11, 95%CI: -0.21 to -0.02) and -0.62; 95% CI: -1.19 to -0.04, respectively).

  20. 2025-03-01

    Revisiting the Montreal Cognitive Assessment in a European cohort of elderly living with type 2 diabetes

    ✓ Peer-reviewed Getting a diagnosis Journal of Alzheimer s Disease

    Key finding: BackgroundIndividuals with type 2 diabetes have an increased risk of developing both vascular and Alzheimer's dementia. +3 more findings

  21. 2025-03-01

    Obfuscation via pitch‐shifting for balancing privacy and diagnostic utility in voice‐based cognitive assessment

    ✓ Peer-reviewed Getting a diagnosis Alzheimer s & Dementia

    Key finding: With the top 20 acoustic features, our framework achieved classification accuracies of 62.2% (EER: 0.3335) on the FHS dataset for NC, MCI, and DE differentiation, and 63.7% (EER: 0.1796) on the DBD dataset for NC and MCI differentiation, using obfuscated speech files. +4 more findings

  22. 2025-03-01

    A Self‐Powered, Shapeable, and Wearable Sensor for Effective Hazard Prevention and Biomechanical Monitoring

    ✓ Peer-reviewed Prevention and risk SmartSys

    Key finding: Flexible and wearable electronics are attracting surging attention due to their potential applications in human health monitoring and precision therapies. +4 more findings

  23. 2025-03-01

    Gender Diversity and Environmental, Social, and Governance: Unlocking Solutions to Corporate Risk

    ✓ Peer-reviewed Prevention and risk Business Strategy & Development

    Key finding: The findings indicate that stronger ESG practices significantly reduce corporate risk, enhance financial stability, and mitigate regulatory and market volatility exposure. +2 more findings

  24. 2025-03-01

    Fast AI Based Amyloid PET Reporting – can Nuclear Medicine Handle the Expected Workload in Alzheimers Diagnostics?

    ✓ Peer-reviewed Biomarkers Nuklearmedizin - NuclearMedicine

    Key finding: The deep-learning network was capable of learning the task of delineating pathologic and normal findings within minutes on a standard PC and performing the classification task with 100% accuracy in less than 1 millisecond per case. +4 more findings

  25. 2025-03-01

    Neuroprotective role of Origanum majorana essential oil loaded in mixed surfactants based nano emulsion against lipopolysaccharide-induced Alzheimer in mice

    ✓ Peer-reviewed Biomarkers Journal of Pharmaceutical Investigation

    Key finding: The current study provides opportunities for safer approaches that using compounds derived from plants and links it to nanotechnology, could be used in the pharmaceutical industry to treat Alzheimer’s disease. +1 more finding

Browse the library by subject, with the full score breakdown →